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Abstract—Effective and non-invasive radiological imaging
based tumor/lesion characterization (e.g., subtype classification)
has long been a major aim in the oncology diagnosis and treat-
ment procedures, with the hope of reducing needs for invasive
surgical biopsies. Prior work are generally very restricted to a
limited patient sample size, especially using patient studies with
confirmed pathological reports as ground truth. In this work,
we curate a patient cohort of 1305 dynamic contrast CT studies
(i.e., 5220 multi-phase 3D volumes) with pathology confirmed
ground truth. A novel fully-automated and multi-stage liver
tumor characterization framework is proposed, comprising four
steps of tumor proposal detection, tumor harvesting, primary
tumor site selection, and deep texture-based characterization.
More specifically, (1) we propose a 3D non-isotropic anchor-free
lesion detection method; (2) we present and validate the use of
multi-phase deep texture learning for precise liver lesion tissue
characterization, named spatially adaptive deep texture (SaDT);
(3) we leverage small-sized public datasets to semi-automatically
curate our large-scale clinical dataset of 1305 patients where four
main liver tumor subtypes of primary, secondary, metastasized
and benign are presented. Extensive evaluations demonstrate that
our new data curation strategy, combined with the SaDT deep
dynamic texture analysis, can effectively improve the mean F1
scores by > 8.6% compared with baselines, in differentiating four
major liver lesion types. This is a significant step towards the
clinical goal.
Index Terms—liver tumor, texture learning, deep learning
I. INTRODUCTION
L IVER cancer is the one of the most highly fatal cancertypes in the world. Identifying lesions is crucial, as treat-
ment strategies vary widely between different categories. Most
liver lesions can be diagnosed non-invasively, using clinical
information coupled with image modalities (e.g. ultrasound,
multi-parametric magnetic resonance imagery (MRI), or multi-
phase dynamic contrast computed tomography (CT)). CT is
the most common choice due to its cost-effectiveness and
fidelity [1], [2]. However, patients with uncertain diagnoses
require invasive procedures, such as biopsies or surgery, which
might lead to unpredictable hemorrhage, infections, and even
death [3]. Thus, improved non-invasive tumor characterization
is a crucial aim within medical imaging analysis [4], [5],
[6], [7], [8], [9], [10], [11], [12]. However, challenges in data
Y. Huo, J. Cai, A. Raju, K. Yan, B. Landman, J. Xiao, L. Lu, A. Harrison
were with the PAII Inc., Bethesda, MD, USA
C. Cheng, C. Liao were with the Chang Gung Memorial hospital, Linkou,
Taiwan, ROC
B.A. Landman were with the Department of Electrical Engineering and
Computer Science, Vanderbilt University, Nashville,TN, USA
Radiology Diagnosis: HCC (Malignant),   Pathology Truth: Benign (FNH)
Radiology Diagnosis : HCC (Malignant),   Pathology Truth: Benign (Hemangioma )
Radiology Diagnosis : ICC (Malignant), Pathology Truth: Metastasis (Malignant)
Fig. 1. Difficult cases in our dataset where radiology diagnoses different from
pathological ones. FNH is short for focal nodular hyperplasia. From left to
right are non-contrast (NC), arterial (A), Venous (V), and Delayed (D) phase
CT images.
collection and analysis remain to be an unsolved problem.
We aim to address these problems, proposing an end-to-end
liver lesion characterization solution that incorporates effective
data-curation, 3D detection, primary tumor selection, and
principled deep texture learning to tackle some of the more
challenging lesion characterization tasks within the clinic.
Why is this a difficult problem? Although clinical diag-
noses from multi-phase CTs are usually performed through
consensus between radiologists and clinicians, misdiagnoses
remain (Fig. 1). For instance, benign and intrahepatic cholan-
giocarcinomas (ICC) lesions can be misinterpreted as hep-
atocellular carcinoma (HCC) [13], [14], with separating
HCC from hemangioma being a particularly pernicious diffi-
culty [15], [16] . Solitary liver metastases are also difficult to
differentiate from ICC [17] (Fig. 1). Underscoring this, a 2006
retrospective study [13], investigating patients receiving a liver
transplant to treat image-determined HCC, discovered that,
20% had benign lesions. Even with new scoring systems, inter-
reader variability is still a problem [18]. We aim to research
computer-aided approaches to alleviate these issues, with many
of the above challenging cases. For methodological chal-
lenges, apart from Xiao et al. [12], all previous approaches
rely on manually drawn tumor region of interests (ROIs). Most
importantly, there are few, if any, prior deep learning based
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Fig. 2. The proposed two-stage framework relies on PTS and SaDT classification, where the former, in turn, consists of detection and KSF. The training
and testing workflows are delineated using dashed and solid lines. 1001 previously unlabeled studies curated by the semi-automated data harvesting. Then all
annotated data are used to train the proposed CenterNet-3D, the KSF, and SaDT models.
methods have been investigated on more than 5000 CT scans
with pathology confirmed liver tumors.
Our approach. Our work is distinct from prior art in
that we not only (1) propose a fully automated end-to-
end framework, but also (2) test our approach on a highly
challenging partically annotated dataset of 1305 multi-phase
CT studies (5220 3D volumes). To meet this challenge, we
develop a fully automated liver lesion classifier using multi-
phase CT, articulating several innovations along the way. A
key engine of our approach is a 3D generalization of CenterNet
detection [19]. During inference this is crucial to localize ROIs
for later downstream classification. Unique to our work, we
employ 3D detection as part of a principled and minimal-labor
data curation workflow, allowing us to harvest and leverage
large-scale hospital data from a small seed dataset. To train our
detector, we show how to employ outside single-phase (single-
channel) data sources [20], [21] to boost multi-phase (multi-
channel) performance. With the curated data in hand, we then
execute classification in two stages. The first stage, called PTS,
uses the aforementioned 3D detector and a primary tumor
classifier, trained using our curated data, to filter proposals
into primary tumor slices. The second stage then applies a deep
texture analysis [22] on these primary tumor slices, providing
a determination of lesion type. To push performance higher,
we use a principled lesion-based pooling method in the texture
analysis. As we demonstrate, deep texture analysis is key to
achieving good performance, and, to the best of our knowledge
we are the first to apply such techniques to the demanding
problem of liver lesion characterization.
Our data. 1305 patients (5220 scans with four volumes
per patient) were selected comprehensively represent various
lesion types, if they had either a liver resection or biopsy,
producing gold-standard, and not image-derived, labels. Im-
portantly, benign lesions represents some of the most chal-
lenging cases, as except for rare cases, these are all lesions
that ideally should not have been biopsied or resected in the
first place, meaning they are very hard to differentiate via CT.
Validating our approach, we demonstrate that our data curation
pipeline and deep texture learning can each boost the four class
classification accuracy by 7.4 and 3.7 percent, respectively.
With the complete pipeline in place, we achieve a mean F1
score of 0.681 in classifying four tumor subtypes, compared to
the top physicians’ performance of F1 = 0.690 when focusing
on the binary HCC vs. non-malignant differentiation of 1-2
centimeter large tumors in CT (or 0.765 under MRI) [23]. As
such, this work represents an step forward toward clinically
useful computer-aided tools for liver lesion characterization.
A. Related Work
Automatic liver lesion characterization. Several previous
works have proposed automatic lesion classifiers. Some only
focus on distinguishing metastasis, cysts and hemangiomas
apart [4], [5], [6], not yet addressing the much more difficult
separation of ICC, HCC, metastasized, and hemangioma le-
sions. Other work tackle this more challenging scenario, e.g.
using manually specified semantic features [7], texture [8],
[9], and deep networks [10], [11], [12]. apart from Xiao et al.
[12], all previous approaches rely on manually drawn tumor
ROIs. In this paper, we develop an effective and automatic 3D
primary tumor identification pipeline, and propose a principled
multi-phase deep texture modeling scheme for precision tumor
characterization.
Liver Lesion Detection. Within the deep learning era
[24], liver tumor detection approaches can be categorized
to segmentation-based detection [24], [25] or pure detection-
based methods [20], [26], with recent work merging these two
into a multi-task design [27]. Most prior work use two-stage
based detection methods, e.g. based on Faster-RCNN [28]
or Mask-RCNN [29]. Yet, recent advanced one-stage meth-
ods [19], [30], [31], [32], [33] have shown excellent perfor-
mance while retaining simpler formulations. Among these,
CenterNet [19] provides a solution well balanced in terms of
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Fig. 3. Liver lesion detection is performed using a 3D CenterNet [19]. The
red and green blobs are the 3D Gaussian kernels for the center points of two
tumors. The lower-right subplot shows the 3D bounding box and a center
point p. Note that the resolution in the direction of D is typically lower than
W and H for CT scans.
complexity and the performance. However, 2D methods can
suffer from inconsistency across slices and high false posi-
tive rates. Therefore, we employ CenterNet as our detection
backbone, but extend it to 3D and tailor it to handle the non-
isotropic nature of medical images.
Deep Texture Learning. Texture analysis has been a
canonical computer vision task for several decades. Traditional
designs consist of three major steps: feature extraction [34],
[35], [36], dictionary based feature encoding [37], [38], [39],
and classification. Recently, classic methods, e.g. Bag-of-
words [39], VLAD [40], and probabilistic version Fisher
vectors (FV) [41], have been supplanted or augmented by
deep texture learning [42], [22], [43], [44]. Unlike the
traditional texture analysis has been widely used in medical
imaging field [45], deep texture learning is not as well studied,
especially for tumor analysis. Given that texture is one of
the most important visual features for the radiologists [46],
texture analysis should be a prominent focus for liver le-
sion characterization. To do this, we adapt the DeepTEN
network [22], which provides an end-to-end CNN solution for
material texture classification. However, we introduce SaDT
to manage the physical meaning of CT pixels and the varying
sizes of lesions, which are considerations not relevant for
canonical material/texture classification. To the best of our
knowledge, we are the first to introduce deep dynamic texture
learning for liver lesion classification.
II. METHODS
Fig. 2 illustrates our overall workflow. First, we register all
CT scans of the same patient together using DEEDS [47].
Then, 3D detection (Sec. II-A) is the first stage, both for
data harvesting (Sec. II-B) and for primary tumor selection
(PTS) (Sec. II-C) . For the second stage, SaDT classifies ROIs
extracted by PTS (Sec. II-D).
A. 3D Detection
As depicted in Fig. 3, we opt for a 3D extension of 2D
CenterNet [19]. We choose the one-stage and anchor-free
CenterNet implementation as it possesses an ideal combination
of high performance and simplicity, without many of the
complicating hyper-parameters required for two-stage and/or
anchor-based approaches. We choose a 3D implementation,
as it proved to be more reliable and natural than the 2D
variant. Throughout, we follow the definition of the terms
from Zhou et al. [19]. Briefly, because CenterNet follows
an fully convolutional network (FCN) pipeline, the primary
outcome is a 3D heatmap, Yˆ ∈ [0, 1]WR ×HR×DR×C , where
C indicates the number of candidate classes while R is the
downsampling factor of the prediction. The heatmap should
equal to 1 at lesion centers and 0 otherwise. As FCN backbone,
we extend the stacked Hourglass-104 network [48] in the
original CenterNet formulation [19] to a 3D variant. Following
standard practice [30], [19], the ground truth of the 3D
target center point can be modeled as a 3D Gaussian kernel.
However, because medical images are typically non-isotropic
(the physical voxel spacing in D, e.g. 5 mm, is larger than that
in W and H , e.g. 1 mm), we propose to utilize a non-isotropic
Gaussian kernel:
Yxyc = exp
(
−
(x−p˜xγx )
2 + (
y−p˜y
γy
)2 + ( z−p˜zγz )
2
2σ2p
)
, (1)
where the p˜x, p˜y , and p˜z are the downsampled target center
points p˜ = b pRc and σp is the kernel standard deviation.
γx, γy , and γz are the resolution coefficients to compensate
for resolution differences. The corresponding pixel regression
loss Lk, and the `1-norm offset prediction loss Loff , are
formulated identically as Zhou et al. [19].
Given a 3D bounding box (x1, y1, z1, x2, y2, z2), the center
point is modeled as p = (x1+x22 ,
y1+y2
2 ,
z1+z2
2 ) [19]. The true
bounding box size is computed as s = (x2−x1, y2− y1, z2−
z1). For a predicted bounding box sˆ, the same L1 loss at the
center point is calculated:
Lsize =
1
N
N∑
k=1
‖sˆk − sk‖1. (2)
We used same hyper-parameter settings as Zhou et al. [19]
to combine the three loss functions (Lk, Loff , Lsize) and to
set σp. Finally, to fit volumes into memory, we first apply an
FCN-based liver segmentation, trained from public data [21],
[49], [50], [51], [52]. We then crop around this liver mask and
resample the resulting region to 176×256×48.
B. Data Harvesting
Since we employ a two-stage approach relying on localiza-
tions, ideally we are given as large a dataset as possible of CT
volumes with bounding-box-labeled primary lesions. However,
in practice it is typical to have only a small cohort of labeled
data, D` = {gi, `i, ζi}N`i=1, where `i and ζi denote image-
level ground truth label and bounding box or mask labels,
respectively. Fortunately, it is often possible to obtain an even
larger cohort of unlabeled data with only image-level labels.
This dataset we denote Du = {gi, `i}Nui=1, where Nu  N`.
Based on our calculations, annotating liver lesion bounding
boxes consumes roughly 15 minutes per CT study (Fig. 7),
making it prohibitive to completely annotate all volumes,
particularly as we wish to develop scalable solutions for large-
scale data. Thus, data curation for Du with minimal labor is
welcome.
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Fig. 4. The data harvesting framework is presented.
Fig. 4 illustrates the straightforward, yet effective, approach
we take. First, we collect a large cohort of public lesions from
the LiTS [21] and DeepLesion [20] datasets. For the latter, we
select for liver lesions using the LesaNet [53] semantic tags.
Using our multi-phase dynamic contrast D` and the single-
phase public data, we train the 3D CenterNet of Sec. II-A.
To harmonize the differing channel numbers between public
and multi-phase data, we simply input all phases as individual
observations to fit any phase as input.
With a detector trained, we then apply it to Du. For
each multi-phase unlabelled volume, we obtain individual
predictions for each phase, which we then merge together
using non-maximal suppression [26]. We then render each
candidate bounding box, along with the corresponding multi-
phase CT intensities, into a 2D image using a grid layout.
These 2D images can then be easily categorized into true
or false positives using a rapid mouse-click-based quality
assurance (QA) process. This takes on average one minute to
verify all candidates per study, reducing annotation labor by
one order of magnitude. While this rapidly filters candidates
into true and false positives, it is still possible to encounter
studies where none of the detection candidates overlapped
with the primary lesion(s). For these cases, they must still be
annotated manually. However, in our case, this number was
only 20% of the original number in Du, meaning the labor
required for annotation has still been dramatically reduced.
With the data curation pipeline in place, we can successfully
harvest bounding boxes for Du, significantly benefiting both
our detection and classification performance. Moreover, the
curation pipeline provides another important benefit, as the
candidate verification provides a cohort of labelled proposals
we can use for the later KSF.
C. Primary Tumor Selection
To implement a fully automatic pipeline, we rely on lo-
calization as a first stage. While we can directly use the
3D detection of Sec. II-A, the data curation of Sec. II-B
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Fig. 5. KSF consists of key slice selection (segmentation) and primary tumor
slice filtering (classification).
demonstrates that additional filtering is required to extract
reliable ROIs. For this reason, we implement a primary tumor
selection (PTS) pipeline for more precise ROI extraction.
Fig. 2 illustrates the PTS workflow. As can be seen, the
first step is to apply the 3D CenterNet detection to generate
primary lesion candidates. We train this implementation using
public datasets, our labeled dataset D`, and the new harvested
lesions in Du from Sec. II-B. From this detector, we extract
the 10 leading candidate 3D bounding boxes per volume. One
or more of these candidates ideally overlaps with primary
lesion(s); however, many will likely also overlap with false
positives, e.g. blood vessels, or non-significant lesions, e.g.
cysts (Fig. 5). These must be filtered out.
For reasons Sec. II-D will explain, and our results support,
downstream classification is performed in 2D. Thus, any lesion
candidate filtering must both select key 2D slices and, from
these, select the most likely one belonging to a primary
tumor. We call this key slice filtering (KSF). As Fig. 5
illustrates, we perform KSF by first applying a binary lesion
segmentation network, trained using D`, on each whole slice
of the volume. Then for each 3D candidate, we choose the
slice corresponding to the greatest prediction area as the key
slice. While in principle any segmentation network can be
incorporated, we choose to finetune the 2.5D segmentation
head of the MULAN lesion detector [27]. We opt for this
model for two reasons: 1) because the segmentation head is
pretrained on DeepLesion [20], it should possess features with
high lesion affinity; and 2) the 2.5D segmentation allows us to
incorporate sufficient background context without downsam-
pling and compromising the resolution.
With key slices selected for each candidate, these must then
be separated into primary and non-primary tumors. To do
this, we perform classification on the multi-phase key slices
(Fig. 5). Fortunately, thanks to the data curation pipeline in
Sec. II-B, we have ample true- and false-positive candidates
to train such a classifier. In this way, the data curation and KSF
steps can be viewed as hard-negative mining and hard-negative
filtering, respectively. Any high-performing classifier can be
used for this step, e.g. well-established appearance based
convolutional neural networks (CNNs) or even the texture-
based classifier we outline next in Sec. II-D.
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D. Texture Classification
With lesion ROIs localized and filtered using the PTS of
Sec. II-C, the next step is to differentiate them into HCC,
ICC, metastasis, or benign (hemangioma, focal nodular hyper-
plasia, and adenoma). Standard CNNs can serve this function,
but texture-based approaches have experienced success [8],
[9], particularly prior to deep learning. For this reason, we
investigate the impact deep texture based approaches. While
it is theoretically possible to perform 3D texture modelling,
practical limitations hamper such an approach. Namely, the
high inter-slice thickness of most CTs, e.g. 5 mm in our data,
is much too coarse to capture texture. Instead, we apply a 2D
deep texture learning workflow, adapting and enhancing the
recent DeepTEN model [22] to create a SaDT network. Using
2D models also allows us to use pretrained models, which is
another key benefit. Fig. 6 depicts our SaDT model.
Following Zhang et al. [22], texture modeling relies on
counting, or soft-counting, the codewords found in a set of
visual descriptors. The visual descriptors, F = {f1, ..., fM},
are generated from the features of an encoding FCN, where M
is the number of spatial locations in the activation map. The
residuals of each feature compared to a set of K codewords
C = {c1, ..., cK} are then computed:
rik = fi − ck, (3)
where i = 1, . . . ,M and k = 1, . . . ,K. Classically these
codewords have been fixed, but recent approaches allow these
to be learned [22]. This is the approach we take.
The set of all M×K residuals must now be aggregated into
a global size K feature describing the overall texture. Before
aggregation, the weights of each encoded residual are com-
puted based on a“soft-assignment” [22]. Traditionally, only a
single weight is assigned to each descriptor xi, called ”hard-
assignment”, but this makes the process non-differentiable.
Therefore, the weight of each rik is calculated using a softmax:
aik =
exp(−sk‖rik‖2)∑K
j=1 exp(−sj‖rij‖2)
, (4)
where sk is the smoothing factor for each cluster center
ck. The smoothing factors are also designed as learnable
parameters, which are updated during the training procedure.
Given the residuals as well as their weights, any arbitrary
set of features, F , can be encoded into a fixed-size K global
vector [22]:
ek =
M∑
i=1
aikrik, (5)
where all spatial locations are aggregated together. However,
different from the canonical scenarios in deep texture learning,
the sizes of the tumors are heterogeneous across different cases
(Fig. 6). A simple resize operation is not optimal, since it
alters the intrinsic physical resolutions to medical imaging. To
address this spatial variations, we propose a spatial adaptive
aggregation that modifies Eq.(5) to
ek =
M∑
i=1
aikrikδi, (6)
where each δi is a 0-1 binary value, indicating if the cor-
responding visual descriptor should be aggregated. In our
implementation, δi is the tumor mask generated using the
segmentation network of Sec. II-C. Despite its straightfor-
wardness, this process, denoted SaDT modelling, can result
in significant performance improvements. Finally, following
standard texture analysis practices [22], [41], [54], the final
output vector is normalized using an `2-norm. Since the
training cohorts are highly unbalanced, for all experiments,
the same weighted focal-loss (γ = 2) [31] is used as the
classification loss function to reconcile the overfitting to the
dominating class. The weights were set to 5 for HCC, 2 for
metastasis, and 1 for remaining classes. The same stochastic
gradient descent (SGD) optimizer with learning rate = 0.004
[22] is used for all experiments.
III. EXPERIMENTS
A. Data
We collected mulit-phase dynamic CT scans from the
archives of Anonymized from patients with liver lesions that
received surgical resection or percutaneous biopsy in the
period between June 2003 to April 2018. CT scans were
acquired from the hospital archives within one month before
the invasive procedure. This resulted in 1305 studies, with
all CT scans having standard 5 mm slice thickness. Most
patients underwent resection (979, 72.2%), with the remainder
receiving biopsy (377, 27.8%) for pathological confirmation.
The dataset was then split into training (1197) and testing
(108) studies, keeping the distribution of lesion types the same.
From the training set, the lesions of 196 studies were manually
segmented under the supervision of a trained clinician (Patho-
200), with the remainder only having image-level labels (Patho-
1000). This corresponds to D` and Du, respectively. Because of
the paucity of certain lesion types, during model development
both Patho-200 and Patho-1000 were split into 5-folds for cross
validation for more stable assessments. Tab. I provides more
data details. The in-plane resolution of all multi-phase scans
6TABLE I
THE DATA USED IN THIS STUDY INCLUDE THE PUBLICLY AVAILABLE LITS AND DEEPLESION DATASET. PATHO IS OUR IN-HOUSE MULTI-PHASE
DYNAMIC CT DATASET, WHICH CONTAINS NON-CONTRAST (NC), ARTERIAL (A), VENOUS (V), AND DELAYED (D) PHASES. PATHO-200, PATHO-VAL,
AND PATHO-TEST ARE MANUALLY ANNOTATED, WHILE PATHO-1000 IS ANNOTATED USING OUR SEMI-AUTOMATED DATA HARVESTING. ALL TRAINING
DATA ARE USED IN DETECTION AND TUMOR HARVESTING, WHILE ONLY PATHO-200 AND PATHO-1000 ARE USED IN TUMOR CHARACTERIZATION.
Dataset Annotation Studies Phases Categories
Train &
Validation
LiTS[21] 3D Seg. 131 V Liver Tumor (131)
DeepLesion (DL)[20] 2D RECIST 2372 Unkown Liver Lesion (2372)
Patho-200 3D Seg. 196 NC,A, V,D HCC(52), ICC(40), Benign(55), Meta(49)
Patho-1000 3D B.Box 1001 NC,A, V,D HCC(921), ICC(4), Benign(2), Meta(74)
Test Patho-test 3D B.Box 108 NC,A, V,D HCC(60), ICC(8), Benign(16), Meta(24)
Click based 
visual QA
3D bounding box
annotation
266 hours
66 hours
Fully Manual Ours
Fig. 7. Labor time using different curation strategies.
are 512 × 512 with averaging 42 slices on z directions. The
average voxel size is 0.69 mm × 0.69 mm × 5 mm.
Since only Patho-200 has localizations, we use the data cura-
tion pipeline from Sec. II-B to extract tumor ROIs from Patho-
1000. In total, this required employing our mouse-click QA
on 1064 lesion candidates (≈ 1 min/study) and executing 3D
bounding box annotations (≈ 15 min/study) on 193 volumes
whose primary tumors were not captured by the proposals. The
labor savings provided by the curation is presented in Fig. 7.
B. Tumor Characterization
We first validate our choice of SaDT model for lesion
characterization, assuming for now that manually drawn ROIs
are available. As comparison, we test against both 3D and
2D classification networks. For a fair comparison, we use an
ImageNet pretrained ResNet-50 backbone for all 2D networks.
For 3D networks, we test ResNet3D [55], [56], while for 2D
networks we test standard ResNet [56] and also the DeepTEN
network [22]. The same single top-1 most confident tumor
(largest volume size) for a give scan is used to train both 3D
and 2D classifiers. For 2D, the top-5 largest area slices are
employed to train the network, while the top-1 largest slices
are used during testing. For 3D, the entire top-1 mask center
cropped tumor volume is used for both training and testing.
Such design ensures only one prediction for each patient,
which enables the validation using image level ground truth.
For DeepTEN, the tumor region within the bounding box
is resized to 256 × 256 following typical texture analysis
practices [22]. For the SaDT method, the bounding box
location is encoded as a binary mask channel for spatial
adaptive aggregation (Fig. 6). When compared against ResNet,
DeepTEN reveals the impact of applying texture analysis vs.
standard appearance-based CNNs. Comparisons against SaDT
reveal the impact of our spatially adaptive approach to deep
texture learning.
We also perform ensembling experiments, which applies all
five models trained in cross validation to the test set with
majority voting. We do not perform ensembling using 3D
methods due to the heavy computational burdens. However,
when using single-model inference, we ensure that the same
train-validation fold is used across all methods. We evaluate
the methods using overall accuracy (Acc.) as well as one-vs.all
F1 scores (F1).
Tab. II presents the results. Some immediate conclusions
can be drawn. First, the inclusion of Patho-1000 significantly
boosts performance for most models, validating our semi-
automatic data curation pipeline. Second, 2D models tend to
perform better than 3D variants. Third, from the 2D models,
texture-based variants outperformed appearance-based ones,
demonstrating the value of applying multi-phase deep texture
learning for lesion characterization. Fourth, unsurprisingly, en-
sembling aided all models. Finally, SaDT achieves the highest,
or nearly highest performance, across all metrics except the F1
benign. While 2D ResNet exhibits the highest performance for
this metric, its other metrics are much worse, whereas SaDT
provides much more stable performance across lesion types.
Thus, these results demonstrate the benefits of applying SaDT
to lesion analysis. Given that these include some of the most
difficult cases to differentiate, these metrics demonstrate the
promise of our lesion characterization strategy.
C. Tumor Detection
While Sec. III-B demonstrates the value of our texture
learning approach, SaDT alone does not provide a complete
pipeline. For this reason, we also validate our detection
network. To do this, we test both the 2D CenterNet [30] as
well as our proposed CenterNet-3D variant. For 2D detection,
CT slices are first normalized to 0.8mm × 0.8mm pixel
size, and then either center cropped or zero padded to 512
× 512. Three consecutive slices (with 2 mm slice thickness)
are used as three input channels. We use the Hourglass [48]
network, pretained on MS-COCO [57], as backbone. Thus the
2D CenterNet represents a strong baseline. For the CenterNet-
3D, liver segmentation, cropping, and resizing is performed
as described in Sec. II-A. The hyper parameters of both
CenterNet-2D [30] and the CenterNet- 3D are optimized based
on the validation dataset. Since the goal is to have the detector
capture the primary tumor in its top 10 candidates, with the
KSF process then filtering these, we measure performance by
the percentage of patients with at least one primary tumor
7TABLE II
WE MEASURE LESION CHARACTERIZATION USING OVERALL ACCURACY (Acc.), MEAN F1 SCORE, AND THE ONE-VS.ALL F1 SCORES.
Patho-200 Patho-1000 Acc. mean F1 F1(HCC) F1(ICC) F1(Benign) F1(Metastasis)
3D ResNet3D [55] X 0.333 0.267 0.451 0.091 0.270 0.255ResNet3D [55] X X 0.583 0.426 0.710 0.182 0.645 0.167
2D
ResNet [56] X 0.565 0.486 0.691 0.250 0.625 0.379
ResNet [56] X X 0.556 0.466 0.636 0.118 0.649 0.462
ResNet-Ensemble X 0.500 0.494 0.606 0.300 0.579 0.490
ResNet-Ensemble X X 0.694 0.594 0.774 0.286 0.750 0.565
DeepTEN [22] X 0.593 0.519 0.679 0.261 0.541 0.596
DeepTEN [22] X X 0.639 0.527 0.742 0.286 0.545 0.533
DeepTEN-Ensemble X 0.528 0.595 0.731 0.455 0.571 0.625
DeepTEN-Ensemble X X 0.685 0.540 0.779 0.286 0.593 0.500
2D (Ours)
SaDT X 0.620 0.541 0.710 0.286 0.526 0.640
SaDT X X 0.713 0.622 0.800 0.421 0.615 0.652
SaDT-Ensemble X 0.657 0.580 0.727 0.316 0.595 0.680
SaDT-Ensemble X X 0.731 0.681 0.797 0.500 0.690 0.735
TABLE III
DETECTION RESULTS. THE PERCENTAGE OF THE PATIENTS WITH AT
LEAST ONE PRIMARY TUMOR IS DETECTED (P1TD) IS PRESENTED.
P1TD-1 MEANS ONLY ONE MOST CONFIDENT PRIMARY TUMOR
DETECTION IS PROVIDED BY THE DETECTOR, WHILE P1TD-10 INDICATES
THE SCENARIOS THAT AT MOST 10 CONFIDENT TUMOR DETECTION
RESULTS ARE OFFERED.
Patho-200 LiTS+DL Patho-1000 P1TD-1 P1TD-10
CenterNet
-2D
X 0.741 0.929
X X 0.714 0.929
X X X 0.786 0.973
CenterNet
-3D (Ours)
X 0.571 0.848
X X 0.732 0.929
X X X 0.795 0.938
TABLE IV
THE KEY SLICE FILTERING (KSF) PERFORMANCE IS PROVIDED.
Accuracy F1(Primary Tumor)
ResNet 0.877 0.888
SaDT (Ours) 0.887 0.891
detected (P1TD). This metric can be divided into whether the
first 1 (P1TD-1) or first 10 (P1TD-10) candidates captured a
primary tumor. P1TD-10 measures whether we are able to even
capture a primary tumor in our candidate cases. But since we
break ties in KSF using detection scores, it is also important
to measure P1TD. We test each variant when trained only on
(A) Patho-200, (B) Patho-200 + public data [21], [20], and (C)
Patho-200 + Patho-1000 + public data, with latter measuring
the impact of our data curation on detection performance.
Tab. III presents the detection results. As can be seen,
incorporating the harvested lesions benefits all models, fur-
ther validating our data curation pipeline. Comparing the
two variants, CenterNet-3D exhibits lower P1TD-10 accuracy
while producing higher P1TD-1 accuracy. Given the complex
interaction, it is difficult to assess which balance between the
two metrics is best. However, as Sec. III-F will demonstrate,
when incorporated within our complete automatic pipeline,
CenterNet-3D corresponds to higher overall performance,
making it our preferred choice.
D. Key Slice Filtering
The first stage of our automatic pipeline, PTS, consists
of both detection and KSF, where the latter selects primary
tumor slices from the detection candidates. A key component
of KSF, in turn, is a classification network to filter out
spurious detections. As such, it is important to characterize
this classifier performance. To do this, we measure classifier
performance on slices extracted from the test set, measuring
a standard ResNet vs. our SaDT. As can be seen in Tab. IV,
both models achieves near 90% accuracy. However, the SaDT
wins out, further validating the model. For this reason, we
employ the SaDT for both KSF and for downstream lesion
classification.
E. Unified Automatic Framework
Finally, we test the contribution of each component to a
unified and fully automatic pipeline. We compare against an
upper bound where lesion ROIs are manually drawn. Note
that, with the PTS model, we now select the top-1 tumor and
top-1 slice using the detection scores and KSF predictions
since the manual segmentation is not available for testing
data as Sec. III-B. We also compare against variants without
KSF, meaning we just select the lesion candidate with the
highest detection score. As Tab. V shows, both CenterNet-
3D and KSF contribute significant performance improvements,
validating our choices. While performance gaps remain com-
pared to a manual approach, these results demonstrate that
our lesion characterization pipeline can provide an effective
fully-automated solution. Given the challenging nature of our
dataset, the results are highly encouraging.
F. Comparing with Human Physicians
Even not a direct comparison, the proposed SaDT achieves
a mean F1 = 0.681 in classifying four tumor subtypes,
compared to the top physicians’ F1 = 0.690 when focusing
8TABLE V
TUMOR CHARACTERIZATION OF AUTOMATIED PIPELINES. THE BEST PERFORMANCE FROM TAB. I IS SHOWN AS THE UPPER BOUND PERFORMANCE.
Acc. mean F1 F1(HCC) F1(ICC) F1(Benign) F1(Metastasis)
Manual Detection + SaDT (Upper Bound) 0.731 0.681 0.797 0.500 0.690 0.735
CenterNet-2D + SaDT 0.565 0.529 0.667 0.500 0.480 0.468
CenterNet-3D + SaDT 0.639 0.521 0.741 0.375 0.455 0.512
CenterNet-2D + KSF + SaDT 0.639 0.538 0.748 0.444 0.435 0.524
CenterNet-3D + KSF + SaDT 0.657 0.583 0.763 0.533 0.476 0.558
on the binary HCC vs. non-malignant differentiation of 1-
2 centimeter large tumors in CT (or 0.765 under MRI)
[23], which is a well-cited clinical study to comprehensively
evaluate physician performance on liver tumor characterization
using CT, MRI, and CEUS. Both [23] and we are using 4-
phase CT, so the basic imaging protocol is comparable in
both studies. (1) However our patient population selection
is more challenging by using only pathologically confirmed
cases (indicates our samples are biased towards patients with
high diagnosis uncertainty by radiology), while [23] only
sampled from a more general population (cirrhotic patients
with nodules). (2) In this work, we are performing fine-grained
four class diagnosis (HCC vs. ICC vs. Meta vs. Benign),
where [23] only does binary classification (HCC vs. others).
(3) When evaluating F1 (HCC vs. remaining) in Table 2,
our methods achieved F1 = 0.797 (Manual+SaDT) and 0.763
(Fully automated), which is considerably higher than F1 =
0.690 using CT in [23], and even comparable with F1 = 0.765
with an advanced MRI protocol in [23].
IV. DISCUSSION
To the best of our knowledge, we are the first to use
deep dynamic CT texture learning for liver tumor charac-
terization. While performance has been pushed on our chal-
lenging dataset, there is room for improvement. Increased
data collection to handle imbalanced training classes (e.g.
≈ 77 % are HCC), would certainly be of benefit. Multi-
center data collection could be a viable strategy, with our
curation pipeline being a key component. Another important
direction is incorporating other radiomic features (e.g. shape
and size) [46], [58]. Finally, it is critical to model prediction
confidences [59], empowering our system to more reliably
provide diagnoses when it is safe to do so. These directions
should push progress even further toward minimizing risky
and painful invasive biopsy and surgical procedures.
Our study is by far one of the largest liver tumor character-
ization work ever reported on 1305 pathologically-confirmed
patients. The patient-wise ground truth labels are converted
to tumor-wise labels using our proposed data harvesting ap-
proach. Osur novel SaDT model is able to adaptively aggregate
over tumor size, location, and deep dynamic texture appear-
ance (in multiphase imaging) as a whole framework of tumor
detection/localization/diagnosis, while [22] mainly exploited
texture cues for the material based 2D image recognition.
In this study, approximately 10% of the cases were used
for testing, which may seem small. However, in absolute
numbers our test set consists of 108 patients (432 multi-
phase CT scans), which is already considerably larger than
previous well known clinical study [23], which studied a total
of 101 nodules...found in 84 patients. Collecting more was
hindered by the labor costs to obtain clinical-quality pixel-
level gold standard annotations, requiring our collaborating
physicians to confirm/annotate each tumor in 3D/4D from both
radiological and pathological reports. On the other hand, our
training dataset is weakly annotated, which allowed for its
comparatively larger size.
We present a fully-automated and unified framework for
liver tumor characterization from multi-phase dynamic CT. We
use a 3D one-stage anisotropic detection network, and employ
it for highly effective semi-automated tumor harvesting and
also tumor ROI extraction during inference. We investigate
liver tumor characterization from a deep texture learning
perspective and propose the spatially adaptive deep texture
(SaDT) network. To bridge 3D detection and 2D classification,
a key slice filtering (KSF) process is proposed that cascades
segmentation and classification. Experiments used a dataset of
1305 multi-phase CTs, all with pathology-proven diagnoses,
that represent some of the most challenging lesion charac-
terization cases. Results demonstrate that our 3D detection,
KSF, and SaDT model all provide significant performance
contributions.
V. CONCLUSION
We present a novel fully-automated multi-stage deep texture
learning framework for liver tumor characterization under
multi-phase dynamic CT. To the best of our knowledge, we
are the first to use deep dynamic CT texture representation
for liver tumor characterization. We employ a 3D anchor-
free anisotropic lesion detection network for highly effective
semi-automated tumor harvesting and tumor ROI extraction
during inference. We exploit the liver tumor characterization
from a deep texture learning perspective by the proposed the
spatially adaptive deep texture (SaDT) network. To bridge 3D
detection and 2D classification, a key slice filtering (KSF)
process is proposed to filter out hard-negatives. Experiments
are conducted on a curated dataset of 1305 multi-phase CT
studies (with pathology-confirmed diagnoses) that represent
some of the most challenging lesion characterization cases.
Results validate that our 3D lesion detection, KSF, and SaDT
models all provide significant performance contributions.
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